A Personnel Problem: We Need More Antimicrobial Researchers, Infectious Disease Clinicians
A decreasing number of researchers and open positions for infectious disease clinicians and limited residency matches are underlying issues that should be addressed to meet the needs around antimicrobial development and clinical care. Amesh Adalja, MD, FIDSA, discusses some of the challenges behind it.
Vanishing Workforce: An Antimicrobial Resistance Threat
This month, world leaders will gather at the UN General Assembly to address the looming threat of antimicrobial resistance (AMR). They will discuss antimicrobial access, governance, coordination, and many other critical aspects of the fight against AMR. Yet there’s one critical component to any successful outcome that is overlooked and underfunded: the dwindling antimicrobial research […]
What Happens When the Last AMR Researcher Turns Off the Lights in the Lab?
Much of modern medicine is possible because of antibiotics. Orthopedic surgeries, caesarean deliveries, and heart and kidney transplants are made safer by antibiotics. Patients who are immunocompromised rely on antibiotics to avoid devastating infections, and those with uncomplicated cystitis, pneumonia and cellulitis feel better after a single course of these amazing products.
NHS launches ‘subscription’ scheme for antibiotics with pharma sector
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse The NHS will agree subscription-style deals with drugmakers for antibiotics, as the UK seeks to encourage the development of new medicines and curb antimicrobial resistance caused by their overuse. The NHS on Monday said it would negotiate fixed fees to […]
Antibiotic innovation is ailing. ‘Brain drain’ may kill it
In today’s labor market, good help is hard to find. For companies developing antibiotics, it’s becoming nearly impossible.
Belgium Developing New Class of Antibiotics, But Incentives and Market Support Needed

Europe’s pipeline of new antibiotics to tackle the growing antimicrobial resistance (AMR) crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives. A recent report by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reveals that between 2017 and 2023, only ten gained approval, with […]
Drug-resistant microbes: ‘brain drain’ is derailing the fight to stop them
A lack of investment is driving researchers who study antimicrobial resistance out of the field, an industry body warns. A lack of funding and incentives for research into antimicrobial resistance (AMR) is causing scientists to leave the field, finds a report published on 8 February by the AMR Industry Alliance, an industry body that brings […]
Report finds brain drain in AMR researchers
The USA-based AMR Industry Alliance conducted a review of publicly available data on the state of antimicrobial resistance (AMR) research and development talent, indicating that researchers are leaving the field of AMR as market dysfunction jeopardizes the investment needed to tackle this growing public health threat.
Report warns of ‘brain drain’ from antibiotic research and development
Two new reports this week from a coalition of industries working to combat antimicrobial resistance (AMR) highlight some of the progress that’s been made, along with a critical problem that could undermine efforts to develop much-needed new antibiotics.
AMR Industry Alliance Finds Exodus of Scientific Talent Threatens Progress Toward Antimicrobial Global Health Threat
Despite its growing death toll, scientific ‘brain drain’ compounds efforts to tackle antimicrobial resistance. Geneva – February 8, 2024 – New analysis published today has identified an exodus of scientific researchers with expertise in antimicrobials as a growing barrier to developing the new antibiotics needed to tackle the rise in antimicrobial resistance. The study estimates […]